1. Home
  2. CRMT vs LEXX Comparison

CRMT vs LEXX Comparison

Compare CRMT & LEXX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo America's Car-Mart Inc

CRMT

America's Car-Mart Inc

HOLD

Current Price

$2.13

Market Cap

19.7M

ML Signal

HOLD

Logo Lexaria Bioscience Corp.

LEXX

Lexaria Bioscience Corp.

HOLD

Current Price

$0.61

Market Cap

16.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CRMT
LEXX
Founded
1981
2004
Country
United States
Canada
Employees
N/A
7
Industry
Other Specialty Stores
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
19.7M
16.5M
IPO Year
2026
N/A

Fundamental Metrics

Financial Performance
Metric
CRMT
LEXX
Price
$2.13
$0.61
Analyst Decision
Buy
Strong Buy
Analyst Count
2
1
Target Price
$29.50
$1.50
AVG Volume (30 Days)
946.4K
81.9K
Earning Date
06-11-2026
04-13-2026
Dividend Yield
N/A
N/A
EPS Growth
147.36
N/A
EPS
N/A
N/A
Revenue
$1,390,932,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$4.92
$601.47
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.38
$0.46
52 Week High
$62.55
$1.55

Technical Indicators

Market Signals
Indicator
CRMT
LEXX
Relative Strength Index (RSI) 21.83 45.49
Support Level $1.38 $0.57
Resistance Level $13.68 $0.70
Average True Range (ATR) 1.49 0.04
MACD -0.43 0.00
Stochastic Oscillator 6.98 33.51

Price Performance

Historical Comparison
CRMT
LEXX

About CRMT America's Car-Mart Inc

America's Car-Mart Inc is an automotive retailer in the U.S. focused exclusively on the Integrated Auto Sales and Finance segment of the used car market. The company's operations are principally conducted through its two operating subsidiaries, America's Car Mart Inc and Colonial Auto Finance. It predominantly sells older model used vehicles and provides financing for substantially all of its customers. It earns revenue from the sale of used vehicles and, in the majority of cases, a related service contract and an accident protection plan product, as well as interest income and late fees from the related financing.

About LEXX Lexaria Bioscience Corp.

Lexaria Bioscience Corp is a biotechnology company focused on enhancing the bioavailability of active pharmaceutical ingredients using its patented DehydraTECH drug delivery technology. DehydraTECH improves absorption, effectiveness, and tolerability and can be applied to APIs such as GLP-1 and GIP drugs, vitamins, pain medications, hormones, antivirals, nicotine and cannabinoids across therapeutic areas including diabetes, weight loss, epilepsy, hypertension, and heart disease. It can be used in formats such as tablets, capsules, oral suspensions, foods, beverages, and pouches, and supports pharmaceuticals, nutraceuticals, over-the-counter products, and consumer packaged goods. The Company operates one segment: IP licensing, generating revenue from licensing its DehydraTECH technology.

Share on Social Networks: